Ecomustine
Alternative Names: CY 233; NSC 609224Latest Information Update: 26 Jul 1994
At a glance
- Originator Sanofi-Synthelabo
- Developer Choay; Sanofi-Synthelabo
- Class Antineoplastics; Nitrosourea compounds; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer